Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
about
Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowthMelatonin in Alzheimer's disease and other neurodegenerative disordersFlavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3Low concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: mechanistic studyThe Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implicationDisease-toxicant interactions in Parkinson's disease neuropathologyDesign innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.Surrogate outcomes in neurology, psychiatry, and psychopharmacologyDiscovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays.Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse modelFungus-derived hydroxyl radicals kill hepatic cells by enhancing nuclear transglutaminase.Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases.Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease.Nicotinamide nucleotide transhydrogenase (Nnt) links the substrate requirement in brain mitochondria for hydrogen peroxide removal to the thioredoxin/peroxiredoxin (Trx/Prx) system.Impact of induced pluripotent stem cells on the study of central nervous system diseaseEffects of Various Flavonoids on the α-Synuclein Fibrillation Process.Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibitionTraumatic stress, oxidative stress and post-traumatic stress disorder: neurodegeneration and the accelerated-aging hypothesis.Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's diseaseNeuroprotective effects of melittin on hydrogen peroxide-induced apoptotic cell death in neuroblastoma SH-SY5Y cellsCriteria for deep-brain stimulation in Parkinson's disease: review and analysis.Drosophila models of neurodegenerative diseases.Dietary flavonoids as potential neuroprotectants.Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways.Regulation of Substantia Nigra Pars Reticulata GABAergic Neuron Activity by H₂O₂ via Flufenamic Acid-Sensitive Channels and K(ATP) ChannelsThe Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localizationAntioxidants as treatment for neurodegenerative disorders.Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease.Crystallizing ideas about Parkinson's diseaseTherapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.Nonselenium glutathione peroxidase in human brain : elevated levels in Parkinson's disease and dementia with lewy bodiesCharacterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants.Protective effect of theaflavins on neuron against 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells.Comparative Proteomic Analysis of Carbonylated Proteins from the Striatum and Cortex of Pesticide-Treated Mice.The aggravating role of the ubiquitin-proteasome system in neurodegeneration.Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function.Evidence from biomarkers and surrogate endpoints.Quercetin and sesamin protect dopaminergic cells from MPP+-induced neuroinflammation in a microglial (N9)-neuronal (PC12) coculture system.
P2860
Q24290518-467E850D-DCBB-42EC-999F-E582E2EA9FBDQ24541302-C99FE39D-DF4C-46AA-9EE8-7793517287DAQ28217483-23432B98-4E77-41D0-BD5F-87AB0935BCC8Q28348876-436BC42F-8F53-4CF9-8716-374378BA458CQ28477457-E3EBAF82-8807-4A01-95F0-DC7EECA15096Q28604244-322147B5-35CF-4EDA-A647-747FBFA35C22Q29248297-DBAB877D-74A0-4B08-BA17-DE2DEA3EAC0EQ30417007-EA59A8D8-607B-4168-A113-2AD00A237991Q30448692-04EA5885-E529-44BB-9710-2B51C6550558Q30473416-E84CC868-9CEC-4FA9-907C-A5B209C9295DQ30865041-7CD6DF9E-8BF7-4069-8518-DA6D95138B0CQ33810589-B71ADA87-A4AD-44F1-8E0E-BC64BF9772D9Q33881464-B5B4A37E-B82C-4D8D-8728-E6A48D416E2DQ33891870-1916816B-F21F-43DC-B6A1-31BD36585D44Q33943273-2971615E-7757-4CA1-BB0A-7AB039FA8873Q34075997-5C05BCD9-FA00-4FF8-9A96-0AAB8C992C24Q34161356-E4C3678F-BB30-474D-B866-D05868C8D99BQ34211735-0EDB51D3-D014-401C-98A4-CEF6AE074D42Q34338754-DF6B85E8-B54F-4132-A844-48E1827DC101Q34415974-1C538EFD-E4C9-4C68-AD3A-2D96F21432A0Q34577087-E1CDD240-9E55-4A2F-B403-5722A0536AC8Q34582215-0786B43B-A4AA-456E-9D1A-4EE0ECA0CA7BQ34587070-D1781FE4-94AD-435A-979B-F7E8181A4619Q34610331-D9CD585B-0696-4385-9C3D-8C09FEC9EEEBQ34658937-742714AF-0AE4-4B40-AF88-0A51A39FC95DQ34675135-8CAEF4CB-FCA5-4A9B-BCE8-62021F546342Q34781654-FCFA306C-BCE8-4E39-8DB2-5115435482AFQ34836156-6FB93CB5-ACE1-4651-BD2F-7C87203F55CFQ34974866-D6DB03C6-32AA-4A85-A2B0-CAE55B6AF950Q35147689-9DD49597-63C5-447E-A6FE-A8C0593CBA94Q35234117-C8DD46E6-9868-494C-80B8-C6529467DD13Q35276597-BB8C7E20-62B6-40CE-B2CC-0D18ADF06D4DQ35789018-39C8E4EA-91B8-42D0-AD51-248327AEC2C0Q35795120-5C7BEDFC-1B48-4FA0-8A8E-2988F0BECAB9Q35829455-C7AB000E-52FF-4605-992F-058254B74732Q35988085-111037D3-4CFA-4E85-988C-9A8B92D10326Q36020204-B06D694B-A376-466B-B403-E6512931B22FQ36042047-427C15AD-57D2-494B-BC36-4F768838B4D3Q36045330-6FAF563A-F864-4E46-9667-879C560B67B0Q36162933-B7C18353-C723-44BF-B3BB-32FD61C59B58
P2860
Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
@ast
Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
@en
Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
@nl
type
label
Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
@ast
Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
@en
Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
@nl
prefLabel
Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
@ast
Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
@en
Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
@nl
P2093
P356
P1476
Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
@en
P2093
P304
P356
10.1006/NBDI.2000.0319
P577
2000-08-01T00:00:00Z